⊕ Affiliate content · we may earn if you start a program · information verified independently

Tirzepatide Cost in 2026: Complete Pricing Guide

Tirzepatide has emerged as the most effective FDA-approved weight loss medication on the market, with clinical trials demonstrating up to 22.5% body weight reduction — surpassing even semaglutide. But its premium efficacy comes at a premium price. A monthly supply of branded Zepbound retails for over $1,200 at most pharmacies, while compound tirzepatide from telehealth providers starts at around $299 per month. This guide breaks down every pricing option available in 2026 — from insurance-covered brand-name tirzepatide to affordable compound alternatives — so you can make an informed decision about this powerful medication.

Tirzepatide Pricing Overview: What You Will Pay

Tirzepatide is sold under two brand names in the United States: Zepbound (FDA-approved for chronic weight management) and Mounjaro (FDA-approved for type 2 diabetes). Both contain the same active molecule but carry different indications, branding, and — in some cases — different insurance coverage rules. At retail pharmacies in 2026, the average prices are: Zepbound (weight management): $1,149–$1,398 per month (10–15 mg maintenance dose) Mounjaro (type 2 diabetes): $1,023–$1,356 per month (10–15 mg maintenance dose) Compound tirzepatide: $249–$449 per month via telehealth providers The pricing landscape for tirzepatide mirrors semaglutide in many ways, but there are important differences. Tirzepatide's dual GIP/GLP-1 mechanism makes it more complex to manufacture, which contributes to slightly higher compound prices compared to compound semaglutide. However, branded tirzepatide is priced competitively with Wegovy, and Eli Lilly has been aggressive about expanding access through savings programs and manufacturing investment. [1] It is worth understanding why tirzepatide commands the prices it does. The SURMOUNT-1 trial showed 22.5% average body weight loss at the 15 mg dose over 72 weeks — the highest ever recorded for an anti-obesity medication. The SURPASS-2 head-to-head trial demonstrated that tirzepatide outperformed semaglutide 1 mg in both glycemic control and weight reduction. For many patients, this superior efficacy justifies the cost, especially when insurance coverage is available.

Zepbound Cost: Brand-Name Pricing Breakdown

Zepbound is Eli Lilly's flagship weight management product, FDA-approved in November 2023 for adults with a BMI of 30 or higher (or 27+ with at least one weight-related comorbidity). It is dosed once weekly via subcutaneous injection, with a titration schedule from 2.5 mg up to a maximum of 15 mg. In 2026, the wholesale acquisition cost (WAC) for Zepbound is approximately $1,234 per 28-day supply. Retail pharmacy prices vary: CVS: $1,287–$1,398 Walgreens: $1,265–$1,375 Walmart Pharmacy: $1,198–$1,312 Costco Pharmacy: $1,175–$1,289 Online/mail-order: $1,149–$1,265 Here is how the actual cost breaks down by insurance situation: With commercial insurance that covers Zepbound: Most patients pay $0–$25 per month after applying the Eli Lilly savings card (Zepbound Savings Card). This card covers up to $563 per fill for eligible commercially insured patients. It is not available to Medicare or Medicaid beneficiaries. With commercial insurance that does NOT cover Zepbound: The savings card reduces the price to approximately $650–$700 per month. Some patients negotiate further discounts through specialty pharmacy programs. Without insurance: Full retail price of $1,149–$1,398 per month. Discount programs like GoodRx can reduce this to approximately $950–$1,150, though prices vary by location and pharmacy. With Medicare Part D: Most Part D plans cover Zepbound. Copays range from $40–$100 per month after deductible. The $2,000 annual out-of-pocket cap (effective 2025 under the Inflation Reduction Act) applies, meaning Medicare patients pay a maximum of $2,000 per year for all prescription drugs combined. [2] Zepbound is available in six dose strengths: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg. All strengths are priced similarly per monthly supply. The titration schedule means patients start at 2.5 mg for the first four weeks and increase by 2.5 mg every four weeks until the target maintenance dose is reached.

Compare GLP-1 pricing

See current prices from top-rated telehealth providers. We may earn a commission. See disclosures.

Compound Tirzepatide: The Affordable Alternative

Compound tirzepatide has become an increasingly popular option for patients who cannot afford branded Zepbound or whose insurance denies coverage. As of 2026, compound tirzepatide is available from several telehealth providers at significantly lower prices than the branded product. Here is a comparison of major providers offering compound tirzepatide in 2026: Henry Meds: $299/month (video consultation, 503B-certified pharmacy, free 2-day shipping) Hims & Hers: $299/month (includes consultation and shipping) Numinous: $397 first month, $347/month after (premium care model) Mochi Health: $249–$299/month (membership model, includes provider access) Ro: $299/month (with optional insurance coordination) All of these providers include a medical consultation, prescription by a licensed provider, and home delivery. Prices typically include the medication itself with no separate pharmacy fees. Compound tirzepatide pricing is generally higher than compound semaglutide at every provider. This reflects the more complex molecular structure of tirzepatide (39 amino acids vs. 31 for semaglutide), higher raw material costs, and the additional GIP receptor agonism that makes the molecule more challenging to compound reliably. [3] The quality considerations are the same as for compound semaglutide. Always verify that your provider uses a 503B-certified compounding pharmacy, confirm the active ingredient is tirzepatide base (not a salt form such as tirzepatide acetate, which the FDA has flagged as unauthorized), and ensure proper dosing instructions are provided. The FDA issued specific warnings in 2024 about compounded tirzepatide salt forms, so this is a critical safety check. Compound tirzepatide is available in dosages matching the branded titration schedule (2.5 mg through 15 mg weekly), though some providers also offer intermediate doses for personalized titration. The medication comes as a lyophilized powder that must be reconstituted with bacteriostatic water and injected subcutaneously using an insulin syringe.

Insurance Coverage for Tirzepatide

Insurance coverage for tirzepatide has expanded significantly since Zepbound's approval, but coverage gaps remain a major barrier for many patients. Here is what to expect across insurance types: Employer-sponsored commercial insurance: Approximately 55-65% of large employer plans cover Zepbound for weight management, slightly behind Wegovy's coverage rate due to its more recent approval. Coverage typically requires a BMI of 30+ (or 27+ with a comorbidity), prior authorization, and documented failure of lifestyle modification. Some plans cover tirzepatide only after a semaglutide failure or step-therapy requirement. ACA marketplace plans: Coverage varies by state and plan tier. Most silver and gold plans cover Zepbound with prior authorization. As of 2026, twelve states plus DC mandate coverage of anti-obesity medications on ACA plans. Medicare Part D: Zepbound and Mounjaro are covered by most Part D plans. Mounjaro (diabetes indication) generally faces fewer prior authorization hurdles than Zepbound (weight management). The $2,000 annual out-of-pocket cap limits total drug spending for Medicare beneficiaries. Medicaid: Approximately 12-15 states cover GLP-1 medications for weight loss under Medicaid, with strict criteria. Mounjaro (diabetes) is covered more broadly than Zepbound (weight management) across state Medicaid programs. Veterans Affairs (VA): The VA formulary includes tirzepatide for eligible veterans with type 2 diabetes (Mounjaro) and, increasingly, for weight management (Zepbound). Copays are typically $11–$31 per 30-day supply. Step therapy requirements: A growing number of insurers require patients to try and fail semaglutide before approving tirzepatide. This "step therapy" protocol can delay access by 3-6 months. If your provider can document a clinical reason to start with tirzepatide (such as a contraindication to semaglutide or a history of inadequate response), they can request a step-therapy override during the prior authorization process. [4] If your insurance denies coverage, you have the right to appeal. Approximately 40-50% of initial GLP-1 denials are overturned on appeal, especially when supported by a detailed letter of medical necessity from your prescriber.

Compare GLP-1 pricing

See current prices from top-rated telehealth providers. We may earn a commission. See disclosures.

How to Save on Tirzepatide: Coupons, Programs, and Strategies

Beyond insurance, there are several strategies to reduce your out-of-pocket cost for tirzepatide: 1. Eli Lilly savings programs: Eli Lilly offers the Zepbound Savings Card, which reduces copays to as little as $0 for commercially insured patients whose plans cover Zepbound. For patients whose plans do not cover Zepbound, the card reduces the price to approximately $650/month. Visit Zepbound.lilly.com to enroll. Eli Lilly also offers a similar program for Mounjaro. 2. Patient assistance programs: Eli Lilly's Patient Assistance Program (Lilly Cares) provides free medication to uninsured patients with household income below 400% of the federal poverty level. Eligibility criteria and applications are available at LillyCares.com. 3. Telehealth compound providers: For patients without insurance coverage or facing high copays, compound tirzepatide from providers like Henry Meds ($299/mo), Hims ($299/mo), or Mochi Health ($249–$299/mo) is significantly cheaper than branded Zepbound, even with a discount. 4. HSA/FSA funds: Tirzepatide prescriptions qualify as eligible medical expenses for Health Savings Accounts and Flexible Spending Accounts. Using pre-tax HSA/FSA dollars effectively reduces the cost by your marginal tax rate (22-32% savings). 5. Pharmacy discount programs: GoodRx, SingleCare, and other discount programs can reduce the retail price of branded tirzepatide by 10-25%. These are most useful for patients paying entirely out of pocket. 6. Dose optimization: Many patients achieve excellent results at doses below the maximum 15 mg. The SURMOUNT trials showed significant weight loss at 10 mg, and some patients maintain results at 7.5 mg. Lower doses may cost less from compound providers and generally produce fewer side effects. Work with your prescriber to find the minimum effective dose. 7. Consider semaglutide first: If cost is the primary concern, compound semaglutide is generally cheaper than compound tirzepatide at every provider. See our semaglutide cost guide for pricing. Semaglutide remains an excellent option with extensive safety data, and you can always switch to tirzepatide later if results are inadequate. [5]

Tirzepatide vs. Semaglutide: Cost-Effectiveness Comparison

When choosing between tirzepatide and semaglutide, cost-effectiveness depends on your individual response, insurance situation, and treatment goals: Branded pricing comparison: - Wegovy (semaglutide 2.4 mg): $1,212–$1,587/month - Zepbound (tirzepatide 10–15 mg): $1,149–$1,398/month - Branded tirzepatide is slightly less expensive than branded semaglutide at most pharmacies Compound pricing comparison: - Compound semaglutide: $85–$399/month - Compound tirzepatide: $249–$449/month - Compound semaglutide is significantly cheaper than compound tirzepatide at every provider Efficacy comparison: - Semaglutide (STEP-1): ~14.9% average weight loss at 68 weeks - Tirzepatide (SURMOUNT-1): ~22.5% average weight loss at 72 weeks - Tirzepatide produces approximately 50% greater weight loss on average Cost per pound lost: For a 200-pound patient losing 14.9% of body weight (30 lbs) on semaglutide at $199/month over 17 months: approximately $6.63 per pound lost. For the same patient losing 22.5% (45 lbs) on tirzepatide at $299/month over 18 months: approximately $7.97 per pound lost. While tirzepatide costs more per month, the dramatically higher weight loss means the per-pound cost is only modestly higher. For patients with commercial insurance covering either medication, both are effectively equivalent in cost ($0–$25/month copay). The decision often comes down to personal factors: if you want maximum weight loss and can afford compound tirzepatide (or have insurance coverage), it may be worth the premium. If cost is the primary constraint, compound semaglutide offers excellent value. See our tirzepatide medication page and semaglutide medication page for detailed clinical comparisons. [1]

Compare GLP-1 pricing

See current prices from top-rated telehealth providers. We may earn a commission. See disclosures.

Hidden Costs and Practical Considerations

When budgeting for tirzepatide treatment, factor in these additional costs beyond the medication itself: Supplies: Compound tirzepatide requires insulin syringes ($15–$30/month), alcohol pads ($5/month), and a sharps container ($10 one-time). Some providers include supplies in the monthly price. Branded Zepbound uses prefilled auto-injector pens, so no separate supplies are needed. Consultation fees: Most telehealth providers include the consultation in their monthly price, but some charge separately ($30–$75 per visit). In-person endocrinology visits may cost $150–$400 without insurance. Lab work: Most providers require baseline bloodwork before prescribing tirzepatide (CBC, metabolic panel, HbA1c, thyroid function, lipase). Without insurance, this costs $100–$300. Many telehealth providers accept recent lab results from your primary care doctor. Follow-up visits: Most telehealth providers include ongoing check-ins. In-person follow-ups with an endocrinologist or obesity medicine specialist may cost $100–$250 per visit without insurance. Nutrition and support: Many patients benefit from nutrition counseling ($50–$150/session) or weight loss support programs. Some telehealth providers include group support or nutrition resources as part of their membership. Titration period costs: The first 4-5 months involve dose escalation (2.5 mg → 5 mg → 7.5 mg → 10 mg → 12.5 mg → 15 mg). During this period, side effects are most common and dose adjustments may be needed. Budget for potential extra provider visits during titration. The total "all-in" cost for compound tirzepatide is typically $270–$380/month including supplies, compared to $1,100–$1,400/month for branded Zepbound with supplies. Over a year, compound tirzepatide can save $8,000–$12,000 compared to branded medication at retail prices. [6]

Pricing comparison — providers in this guide

Provider Price Meds Score
Henry Meds Editor's Choice $249 /mo starting
SemaTirz
9.4 Visit →
Ro Best Brand Trust $199 /mo starting
SemaTirz
9.1 Visit →
Hims Best Value $199 /mo all-in
SemaTirz
8.6 Visit →

Affiliate disclosure: GoGLP1 earns a commission from qualifying enrollments. This never affects our rankings. Reviewed 2026.

Find the best price for your GLP-1

Start with a free consultation — most providers accept insurance. See disclosures.

References

  1. [1]Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). N Engl J Med. 2022;387(3):205-216.
  2. [2]Centers for Medicare & Medicaid Services. Medicare Part D Drug Coverage and Inflation Reduction Act Provisions. 2025-2026.
  3. [3]U.S. Food and Drug Administration. 503B Outsourcing Facilities: Regulatory Framework and Compounding Quality Standards. Updated 2026.
  4. [4]Kaiser Family Foundation. Coverage of GLP-1 Agonists for Weight Loss by Private Health Plans. 2025.
  5. [5]Eli Lilly and Company. Zepbound (tirzepatide) Prescribing Information and Savings Programs. Updated 2026.
  6. [6]GoodRx Research. Tirzepatide Pricing Trends: Brand vs. Compound. Q1 2026.

§ FAQ — Common questions about cost

What is the cheapest way to get tirzepatide?

The cheapest way to get tirzepatide depends on your situation. If you have commercial insurance that covers Zepbound, the Eli Lilly savings card can reduce your copay to $0–$25/month. Without insurance, compound tirzepatide from Mochi Health ($249–$299/month) or Henry Meds ($299/month with video consultation and 503B pharmacy) is the most affordable option. Uninsured patients meeting income requirements can apply for free branded Zepbound through the Eli Lilly Patient Assistance Program (Lilly Cares). Always verify that any compound provider uses a licensed compounding pharmacy and prescribes tirzepatide base — not unauthorized salt forms.

Does insurance cover tirzepatide for weight loss?

Approximately 55-65% of large employer plans cover Zepbound for weight management, typically requiring a BMI of 30+ (or 27+ with comorbidities), prior authorization, and documented lifestyle modification. Some plans require step therapy — trying and failing semaglutide first. Medicare Part D covers Zepbound with the $2,000 annual out-of-pocket cap. Medicaid coverage varies by state (about 12-15 states cover it). If denied, appeal the decision — about 40-50% of GLP-1 denials are overturned with a strong letter of medical necessity.

Is compound tirzepatide as effective as Zepbound?

Compound tirzepatide uses the same active pharmaceutical ingredient (API) as branded Zepbound. Clinical effectiveness depends on compounding quality, accurate dosing, and proper storage. The FDA notes that compounded drugs are not FDA-approved and may vary in quality, but 503B-certified compounding pharmacies operate under stringent quality controls. Many patients report comparable results with compound tirzepatide from reputable providers. No head-to-head clinical trials comparing branded and compound tirzepatide have been published. Always verify that your provider uses tirzepatide base (not salt forms like tirzepatide acetate, which the FDA has warned against).

How much does tirzepatide cost per month without insurance?

Without insurance, branded Zepbound costs $1,149–$1,398/month at retail pharmacies (or $950–$1,150 with discount programs). Compound tirzepatide from telehealth providers costs $249–$449/month. Mochi Health offers the lowest compound tirzepatide price at $249–$299/month, while Henry Meds charges $299/month with video consultation and 503B pharmacy sourcing. Compound tirzepatide is generally $50–$100/month more expensive than compound semaglutide at the same provider.

Should I choose tirzepatide or semaglutide?

Both are highly effective GLP-1 medications. Tirzepatide produces approximately 50% greater weight loss on average (22.5% vs. 14.9%) but costs more as a compound ($249–$449 vs. $85–$399/month). With insurance, both can cost as little as $0–$25/month with manufacturer savings cards. If maximum weight loss is your priority and you can afford the higher compound price, tirzepatide may be the better choice. If cost is the primary concern, compound semaglutide offers excellent value. Some patients start with semaglutide and switch to tirzepatide if they plateau. See our <a href="/cost/semaglutide-cost/">semaglutide cost guide</a> for detailed pricing.

HIPAA Compliant Protected health data
503B Pharmacy Licensed compounding
Board Reviewed Medical oversight
FDA Registered Regulated facilities
Editor's Choice · Henry Meds
From $249/mo starting · Free 2-day shipping
Start → Affiliate link